Ogata M, Kotaka M, Ogata T, Hatachi Y, et al. Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan. PLoS One 2020;15:e0234314.
PMID: 32530932